secwatch.observer — SEC 8-K summary
======================================

Issuer:     Clene Inc. (CLNN)
CIK:        0001822791
Form:       8-K
Filed at:   2021-08-09T23:59:59+00:00
Accession:  0001213900-21-041062
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Clene appoints Dr. Vallerie McLaughlin as independent director, effective August 5, 2021
--------------------------------------------------------------------------------

- Appointed Vallerie V. McLaughlin, M.D. as Class III director and member of Nominating and Corporate Governance Committee.
- Received option award for 45,000 shares at $9.37 exercise price, vesting in 36 monthly installments.
- Also received immediate options valued at $11,000 (Board $10,000 + committee $1,000) at $9.37 exercise price.
- Dr. McLaughlin is professor at University of Michigan, expert in pulmonary hypertension rare disease trials.
- She becomes the seventh independent director on the seven-member board.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1822791/000121390021041062/0001213900-21-041062-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1822791/000121390021041062/ea145457-8k_cleneinc.htm
  HTML page:      https://secwatch.observer/filing/0001213900-21-041062

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer